Browsing: Chiesi

Italy’s Chiesi is gearing up to acquire US-listed KalVista Pharmaceuticals for an impressive $1.9 billion, signaling a bold leap to expand its rare disease and drug development portfolio, Reuters reports. This landmark deal highlights the growing surge of cross-border investments transforming the pharmaceutical landscape

Chiesi has invested €430 million in a new facility in Italy, aiming to bolster its production capabilities. Meanwhile, Bharat Biotech has inaugurated its first cell and gene therapy (CGT) site in India, marking a significant advancement in the region’s biopharmaceutical landscape.